ArticleNature communications2025
Enhancing diagnostic accuracy in rare and common fundus diseases with a knowledge-rich vision-language model.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- AI-based clinician decision support system for diagnosis of inherited retinal diseases: a multicenter, randomized trial.Nature medicine · 2026Trial
- The Underutilized Ocular Fundus in Emergency Departments: Current Progress and Future Prospect of Imaging and Artificial Intelligence for Patient Care.Ophthalmology science · 2026Review
- A Text-Guided Lesion Mining Vision-Language Ordinal Classification Framework for Diabetic Retinopathy Grading.Journal of imaging · 2026Article
- From generalization to precision: A large domain-specific pretrained model for specialized medical tasks.Cell reports. Medicine · 2026Article
- MRICombo: a deep-learning-based framework for universal volumetric segmentation grading-staging and malignancy detection across heterogeneous MRI.Nature communications · 2026Article
- Learning Ophthalmologist Clinical Reasoning for Glaucoma Diagnosis from Fundus Images.medRxiv : the preprint server for health sciences · 2026Article
- Current Applications of Artificial Intelligence in Neuro-Ophthalmic Imaging: A Narrative Approach.Medical sciences (Basel, Switzerland) · 2026Review
- Medical Vision-Language Models: Existing Technologies, Clinical Applications and Future Directions.Sensors (Basel, Switzerland) · 2026Review
- A gated task-attentive multi-task network for unified retinal image analysis.Scientific reports · 2026Article
- Comparative Analysis of General-Purpose vs. Domain-Specific Multimodal Models for Diabetic Retinopathy Classification.Diagnostics (Basel, Switzerland) · 2026Article
- Centering the marginalized: AI-driven strategies for advancing health equity in rare disease care.Patterns (New York, N.Y.) · 2026Review
- OBUSight: Clinically Aligned Generative AI for Ophthalmic Ultrasound Interpretation and Diagnosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Understanding pre-training data effects in retinal foundation models using two large fundus cohorts.Nature communications · 2026Article
- Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis.Progress in retinal and eye research · 2026Review
- Benchmarking Vision Encoders for Image Classification in Ophthalmology.Computational and structural biotechnology journal · 2026Article
- Compact vision language models enable efficient and interpretable optical coherence tomography through layer-specific multimodal learning.Communications medicine · 2025Article
- AI-driven enhancements in rare disease diagnosis and support system optimization.Intractable & rare diseases research · 2025Article
- Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction.Briefings in bioinformatics · 2025Review
- A systematic review of vision and vision-language foundation models in ophthalmology.Advances in ophthalmology practice and researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
49 authors.
Funding
Abstract
Previous foundation models for fundus images were pre-trained with limited disease categories and knowledge base. Here we introduce RetiZero, a vision-language model that incorporates knowledge from over 400 fundus diseases. The model is pre-trained on 341,896 fundus images with accompanying text descriptions gathered from diverse sources across multiple ethnicities and countries. RetiZero demonstrates exceptional performance across various downstream tasks including zero-shot disease recognition, image-to-image retrieval, clinical diagnosis assistance, few-shot fine-tuning, and cross-domain disease identification. In zero-shot scenarios, it achieves Top-5 accuracies of 0.843 for 15 diseases and 0.756 for 52 diseases, while for image-to-image retrieval, it scores 0.950 and 0.886 respectively. Notably, RetiZero's Top-3 zero-shot performance exceeds the average diagnostic accuracy of 19 ophthalmologists from Singapore, China, and the United States. The model particularly enhances clinicians' ability to diagnose rare fundus conditions, highlighting its potential value for integration into clinical settings where diverse eye diseases are encountered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.